Qidong Biotechnology Park in Qidong, Nantong, Jiangsu province. [Photo/WeChat account: qidongfabu]

Qidong Biotechnology Park, supported by a robust industrial policy system, comprehensive service platforms, and sophisticated infrastructure, is fostering the development of the Yangtze River Delta region's health industry.

The park has constructed a variety of facilities including incubators, accelerators, and research and development buildings, catering to the diverse needs of pharmaceutical and medical device companies in areas such as research, pilot testing, and small-scale production.

Jiang Bokun, a project manager from Chemvon Biotechnology (Nantong) Co Ltd, stated that the park's scientific and targeted spatial planning meets the demands of modern production and high-quality living. These measures, including customized production plants and commercial and living facilities, are unparalleled in the Yangtze River Delta region.

To address common challenges such as large investments, a long payback period, and high risks faced by biopharmaceutical businesses, Qidong Biotechnology Park has closely collaborated with fund companies to optimize capital services, particularly by encouraging investments in startups and small innovative companies. The park encourages both State-owned enterprises and the use of social capital to increase financial support for technology enterprises.

The park also tailors supportive policies for startups, small and medium-sized enterprises, and large enterprises at different stages of development, as well as for different aspects of enterprise activities such as research and development, production, and sales. These policies are highly-targeted and competitive, facilitating the growth of enterprises in the park.